Skip to content
NBDC Human Database

No datasets in the cart.

Go to the cart

Due to system maintenance, the application system, application review by the Data Access Committee will be unavailable during the following period.
Schedule: October 5th (Mon), 2026, 9:00 - October 7th (Wed), 2026, 15:00 (JST)
We apologize for any inconvenience this may cause and appreciate your understanding.

We are currently receiving a large number of applications for data submission, and the review process is taking longer than usual.We sincerely apologize for the delay and kindly ask for your understanding. When submitting an application, we would greatly appreciate it if you could allow sufficient time for the processing.

Following a change to our organizational structure effective April 1, 2026, this division has been renamed from the "Database Center for Life Science, Joint Support-Center for Data Science Research" to the "Database Division for Life Science (DBCLS), BioData Science Initiative (BSI), National Institute of Genetics (NIG)". Where the former name still appears in the guidelines, please read it as the new name.

Release info for hum0195

  • hum0195-v3

    2022-03-18
    Datasets added in this release

    No datasets were added.

    Release note
    DNAs extracted from tumor tissues, non-tumor tissues, and peripheral blood samples of 1 patients with gastric cancer were used for whole exome sequencing (fastq files).

  • hum0195-v2

    2022-03-02
    Datasets added in this release
    Release note
    DNAs extracted from tumor tissues, non-tumor tissues, and peripheral blood samples of 36 patients with gastric cancer and 3 patients with gastric submucosal tumor patients were used for whole exome sequencing and target capture sequencing analyses (fastq files).
    Total RNAs extracted from non-tumor tissues (only gland duct) of 5 IM samples and 3 non-IM samples were used for RNA sequencing analysis (fastq files).

  • hum0195-v1

    2021-03-26
    Datasets added in this release
    Release note
    - DNAs extracted from tumor tissues, non-tumor tissues, and lymphocytes isolated from peripheral blood of 5 nodule-in-nodule hepatocellular carcinoma patients were used for whole genome sequencing analyses (fastq files).
    - DNAs/RNAs extracted from tumor tissues, non-tumor tissues, and lymphocytes isolated from peripheral blood of 20 liver cirrhosis and hepatocellular carcinoma after hepatitis C virus eradication, 3 hepatitis C virus positive cirrhosis and hepatocellular carcinoma and 2 hepatitis C virus negative hepatocellular carcinoma patients were used for whole exome sequencing and RNA sequencing analysis (fastq files).